• Policy
• High-priced drugs receive reimb in the new year
• by Lee, Tak-Sun Jan 17, 2024 05:29am

• Policy
• Caution required for use of ADHD drug methylphenidate
• by Lee, Hye-Kyung Jan 16, 2024 06:09am

• Policy
• AHA drug Obizur to soon receive reimb in Korea
• by Lee, Tak-Sun Jan 12, 2024 07:06am

• Policy
• Enhertu’s reimb to be redeliberated at next DREC meeting
• by Lee, Tak-Sun Jan 12, 2024 07:05am

• Policy
• HIRA establishes new Pharmaceutical Benefits Dept
• by Lee, Tak-Sun Jan 11, 2024 05:44am

• Policy
• MFDS to resolve production of chemotherapy drug '5-FU'
• by Lee, Hye-Kyung Jan 10, 2024 05:42am

• Policy
• Will Enhertu be discussed in this year’s 1st DREC meeting?
• by Lee, Tak-Sun Jan 10, 2024 05:42am

• Policy
• Data Exclusivity Bill for IMDs may soon be legislated
• by Lee, Jeong-Hwan Jan 9, 2024 05:49am

• Policy
• Need to specify conditions for postponing PE data submission
• by Lee, Tak-Sun Jan 5, 2024 05:41am

• Policy
• Moderna produced the most drugs in Korea in 2023
• by Lee, Hye-Kyung Jan 4, 2024 05:33am